DJS Antibodies is a startup based in the United Kingdom, most recent round Acquired, 3 tracked investors.
DJS Antibodies is a startup based in the United Kingdom. DJS Antibodies has been acquired. Brouky records 3 investors associated with the company.
DJS Antibodies was a biotechnology company based in Oxford, UK, specializing in the discovery and development of antibody-based therapeutics. They focused on targeting G protein-coupled receptors (GPCRs) for autoimmune and inflammatory diseases, and were acquired by AbbVie in 2022.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.